Longitudinal analysis of tyrosine kinase inhibitor therapy outcomes and BCR‐ABL1 transcript decline velocity in chronic myeloid leukemia: A 16‐year real‐world study. - Mustafa Ali, Moaath K.; Zabor, Emily C.; Abdurakhmanov, Kamilla; Zureigat, Hadil; Mohamed, Ahmed N.; Alchirazi, Muaz Alsabbagh; Dhakal, Aastha; Mushtaq, Ali; Rehman, Naveen; Bawwab, Ameed; Berube, Bryan; Khatib, Lana; et al. (Cancer (0008543X), 2026)